Dr Tiffany Leung joined the School of Public Health as a Post-doctoral Fellow in 2025. She earned her PhD in Cancer Outcomes Research from the University of Hong Kong in 2023, where her research focused on big data analyses and trial reproducibility. Prior to her PhD, she obtained a Bachelor of Public Health from National Taiwan University and a Master of Science in Global Health Policy from the University of Edinburgh, with a special focus on long-term care policies. Dr Leung’s research interests include machine learning algorithms, big data analysis, and aging-related issues.

1. Matousek, A., Leung, T. H., & Pang, H. (2025). Multivariate time series clustering analysis of the Global Dietary Database to uncover patterns in dietary trends (1990–2018). Public Health Nutrition, 28(1), e89.
2. Leung, T. H., Ho, J. C., Wang, X., Lam, W. W., & Pang, H. H. (2024). The impact of lowering the study design significance threshold to 0.005 on sample size in randomized cancer clinical trials. Journal of Clinical and Translational Science, 8(1), e9.
3. Leung, T. H., El Helali, A., Wang, X., Ho, J. C., & Pang, H. (2023). Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019. Cancer Medicine, 12(24), 22316-22324.
4. Leung, T. H., Ho, J. C., Wang, X., & Pang, H. (2023). Assessing surrogacy using restricted mean survival time ratio for overall survival in liver cancer: a narrative review. Chinese Clinical Oncology, 12(5), 53-53.
5. Leung, T. H., Ho, J. C., El Helali, A., Vokes, E. E., Wang, X., & Pang, H. (2023). New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach. Annals of Translational Medicine, 11(1), 2.
6. Pang, H., Yang, G., Ho, J. C., Leung, T. H., Shi, Q., Hu, C., ... & Wang, X. (2022). Assessing surrogacy using restricted mean survival time ratio for overall survival in non-small cell lung cancer immunotherapy studies. Chinese clinical oncology, 11(1), 7-7.